Espen Molden
- Pharmacology top 0.1%
- Psychiatry and Mental health top 1%
- Pediatrics, Perinatology and Child Health top 1%
- Pharmacology top 1%
- Oncology top 5%
- Co-authors
- Tore HaslemoMonica HermannMagnus Ingelman‐SundbergMarin M. JukićHelge RefsumRobert L. SmithIda RudbergHege Christensen
- Topics
- Pharmacogenetics and Drug Metabolism (95 papers)Schizophrenia research and treatment (63 papers)Pharmacological Effects and Toxicity Studies (36 papers)
In The Last Decade
Espen Molden
176 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 127
- Pharmacology 1.5k
- Psychiatry and Mental health 1.3k
- Pediatrics, Perinatology and Child Health 753
- Pharmacology 671
- Oncology 518
Countries citing papers authored by Espen Molden
This map shows the geographic impact of Espen Molden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Espen Molden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Espen Molden more than expected).
Fields of papers citing papers by Espen Molden
This network shows the impact of papers produced by Espen Molden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Espen Molden. The network helps show where Espen Molden may publish in the future.
Co-authorship network of co-authors of Espen Molden
This figure shows the co-authorship network connecting the top 25 collaborators of Espen Molden. A scholar is included among the top collaborators of Espen Molden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Espen Molden. Espen Molden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 5 | |
| 8 | 10 | |
| 9 | 15 | |
| 10 | 12 | |
| 11 | 4 | |
| 12 | 17 | |
| 13 | 19 | |
| 14 | 3 | |
| 15 | 21 | |
| 16 | 19 | |
| 17 | 22 | |
| 18 | 35 | |
| 19 | 12 | |
| 20 | Frukt og bær – interaksjoner med legemidler | 0 |
About Espen Molden
Espen Molden is a scholar working on Pharmacology, Psychiatry and Mental health and Geriatrics and Gerontology, having authored 184 papers that have together received 3.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (95 papers), Schizophrenia research and treatment (63 papers) and Pharmacological Effects and Toxicity Studies (36 papers). The work is most often cited by research in Pharmacology (1.5k citations), Geriatrics and Gerontology (382 citations) and Biological Psychiatry (240 citations). Espen Molden has collaborated with scholars based in Norway, Sweden and Serbia. Frequent co-authors include Tore Haslemo, Monica Hermann, Magnus Ingelman‐Sundberg, Marin M. Jukić, Helge Refsum, Robert L. Smith, Ida Rudberg, Hege Christensen, H. Refsum and Anders Åsberg. Their work appears in journals such as PLoS ONE, American Journal of Psychiatry and Biological Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.